May 2, 2024

Biotalys Starts Field Trials for Second Biofungicide

PDF icon
EN PDF icon
NL
April 30, 2024

Biotalys Appoints Laura J. Meyer to Board of Directors

PDF icon
EN PDF icon
NL
April 23, 2024

Results of the Ordinary and Extraordinary Shareholders’ Meeting

PDF icon
EN PDF icon
NL
March 29, 2024

Results of the Special Shareholders’ Meeting

PDF icon
EN PDF icon
NL
March 20, 2024

Invitation to the ordinary general shareholders meeting and an extraordinary shareholders meeting

PDF icon
EN PDF icon
NL
March 18, 2024

Biotalys and Novonesis announce manufacturing and commercialisation partnership for EVOCA NG

PDF icon
EN PDF icon
NL
February 26, 2024

Invitation to a Special Shareholders’ Meeting

PDF icon
EN PDF icon
NL
February 22, 2024

Biotalys Reports Full-Year 2023 Financial Results and Business Highlights

PDF icon
EN PDF icon
NL
February 8, 2024

Biotalys Enters into Academic Collaborations with Key Scientific Leaders in Europe and U.S.

PDF icon
EN PDF icon
NL
January 31, 2024

Information on the total number of voting rights and shares

PDF icon
EN PDF icon
NL
January 22, 2024

Biotalys Notice of Full Year 2023 Results and Business Highlights

PDF icon
EN PDF icon
NL
December 19, 2023

Biotalys Announces Results of Independent Field Trials in the U.S.

PDF icon
EN PDF icon
NL
November 29, 2023

Biotalys Provides Company Update

PDF icon
EN PDF icon
NL
October 5, 2023

Kevin Helash commences role as Chief Executive Officer of Biotalys

PDF icon
EN PDF icon
NL
October 2, 2023

Biotalys announces the appointment of Kevin Helash as Chief Executive Officer and Director to lead the company in its next growth phase

PDF icon
EN PDF icon
NL